Rathmell WK - Search Results

1

Diagnostic accuracy of contrast-enhanced ultrasound for characterization of kidney lesions in patients with and without chronic kidney disease.

Chang EH, Chong WK, Kasoji SK, Fielding JR, Altun E, Mullin LB, Kim JI, Fine JP, Dayton PA, Rathmell WK. Chang EH, et al. Among authors: rathmell wk. BMC Nephrol. 2017 Aug 9;18(1):266. doi: 10.1186/s12882-017-0681-8. BMC Nephrol. 2017. PMID: 28793871 Free PMC article. Clinical Trial.

2

The loss of radiographic enhancement in primary renal cell carcinoma tumors following multitargeted receptor tyrosine kinase therapy is an additional indicator of response.

Cowey CL, Fielding JR, Rathmell WK. Cowey CL, et al. Among authors: rathmell wk. Urology. 2010 May;75(5):1108-13.e1. doi: 10.1016/j.urology.2009.06.105. Epub 2009 Nov 20. Urology. 2010. PMID: 19931124

3

Neoadjuvant clinical trial with sorafenib for patients with stage II or higher renal cell carcinoma.

Cowey CL, Amin C, Pruthi RS, Wallen EM, Nielsen ME, Grigson G, Watkins C, Nance KV, Crane J, Jalkut M, Moore DT, Kim WY, Godley PA, Whang YE, Fielding JR, Rathmell WK. Cowey CL, et al. Among authors: rathmell wk. J Clin Oncol. 2010 Mar 20;28(9):1502-7. doi: 10.1200/JCO.2009.24.7759. Epub 2010 Feb 16. J Clin Oncol. 2010. PMID: 20159822 Free PMC article. Clinical Trial.

4

Management of Indeterminate Cystic Kidney Lesions: Review of Contrast-enhanced Ultrasound as a Diagnostic Tool.

Chang EH, Chong WK, Kasoji SK, Dayton PA, Rathmell WK. Chang EH, et al. Among authors: rathmell wk. Urology. 2016 Jan;87:1-10. doi: 10.1016/j.urology.2015.10.002. Epub 2015 Oct 19. Urology. 2016. PMID: 26483268 Free PMC article. Review.

5

Alternate Metabolic Programs Define Regional Variation of Relevant Biological Features in Renal Cell Carcinoma Progression.

Brooks SA, Khandani AH, Fielding JR, Lin W, Sills T, Lee Y, Arreola A, Milowsky MI, Wallen EM, Woods ME, Smith AB, Nielsen ME, Parker JS, Lalush DS, Rathmell WK. Brooks SA, et al. Among authors: rathmell wk. Clin Cancer Res. 2016 Jun 15;22(12):2950-9. doi: 10.1158/1078-0432.CCR-15-2115. Epub 2016 Jan 19. Clin Cancer Res. 2016. PMID: 26787754 Free PMC article.

6

A Pilot Clinical Study in Characterization of Malignant Renal-cell Carcinoma Subtype with Contrast-enhanced Ultrasound.

Kasoji SK, Chang EH, Mullin LB, Chong WK, Rathmell WK, Dayton PA. Kasoji SK, et al. Among authors: rathmell wk. Ultrason Imaging. 2017 Mar;39(2):126-136. doi: 10.1177/0161734616666383. Epub 2016 Sep 22. Ultrason Imaging. 2017. PMID: 27659687 Free PMC article.

7

Associations between Tumor Vascularity, Vascular Endothelial Growth Factor Expression and PET/MRI Radiomic Signatures in Primary Clear-Cell-Renal-Cell-Carcinoma: Proof-of-Concept Study.

Yin Q, Hung SC, Wang L, Lin W, Fielding JR, Rathmell WK, Khandani AH, Woods ME, Milowsky MI, Brooks SA, Wallen EM, Shen D. Yin Q, et al. Among authors: rathmell wk. Sci Rep. 2017 Mar 3;7:43356. doi: 10.1038/srep43356. Sci Rep. 2017. PMID: 28256615 Free PMC article.

8

Ultrasound Molecular Imaging of VEGFR-2 in Clear-Cell Renal Cell Carcinoma Tracks Disease Response to Antiangiogenic and Notch-Inhibition Therapy.

Rojas JD, Lin F, Chiang YC, Chytil A, Chong DC, Bautch VL, Rathmell WK, Dayton PA. Rojas JD, et al. Among authors: rathmell wk. Theranostics. 2018 Jan 1;8(1):141-155. doi: 10.7150/thno.19658. eCollection 2018. Theranostics. 2018. PMID: 29290798 Free PMC article.

9

Ultrasound Measurement of Vascular Density to Evaluate Response to Anti-Angiogenic Therapy in Renal Cell Carcinoma.

Rojas JD, Papadopoulou V, Czernuszewicz TJ, Rajamahendiran RM, Chytil A, Chiang YC, Chong DC, Bautch VL, Rathmell WK, Aylward S, Gessner RC, Dayton PA. Rojas JD, et al. Among authors: rathmell wk. IEEE Trans Biomed Eng. 2019 Mar;66(3):873-880. doi: 10.1109/TBME.2018.2860932. Epub 2018 Jul 27. IEEE Trans Biomed Eng. 2019. PMID: 30059292 Free PMC article.

10

Pilot Study of [¹⁸F] Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)/Magnetic Resonance Imaging (MRI) for Staging of Muscle-invasive Bladder Cancer (MIBC).

Eulitt PJ, Altun E, Sheikh A, Wong TZ, Woods ME, Rose TL, Wallen EM, Pruthi RS, Smith AB, Nielsen ME, Whang YE, Kim WY, Godley PA, Basch EM, David GU, Ramirez J, Deal AM, Rathmell WK, Chen RC, Bjurlin MA, Lin W, Lee JK, Milowsky MI. Eulitt PJ, et al. Among authors: rathmell wk. Clin Genitourin Cancer. 2020 Oct;18(5):378-386.e1. doi: 10.1016/j.clgc.2020.02.008. Epub 2020 Mar 6. Clin Genitourin Cancer. 2020. PMID: 32147364

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

306 results

Search Page